IL22 and polycystic ovary syndrome: We found that the administration of IL-22 to DHEA-treated Fshrcre−Stat3f/f mice significantly alleviated irregular estrous cycle (Fig. 4A, C), polycystic ovaries (Fig. 4B) and increased corpus luteum numbers (Fig. 4D).